Geode Capital Management, LLC F Star Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$5.41 - $6.74 $38,102 - $47,469	7,043 Added 3.94%	185,982 $952,000
Q2 2022 Aug 12, 2022	BUY	$2.18 - $6.39 $73,047 - $214,116	33,508 Added 23.04%	178,939 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$5.2 - $8.42 $78,790 - $127,579	15,152 Added 11.63%	145,431 $1.06 Million
Q2 2021 Aug 13, 2021	BUY	$6.57 - $10.71 $494,583 - $806,238	75,279 Added 136.87%	130,279 $1.12 Million
Q1 2021 May 12, 2021	BUY	$7.09 - $13.84 $252,886 - $493,645	35,668 Added 184.5%	55,000 $595,000
Q4 2020 Feb 12, 2021	BUY	$1.03 - $10.39 $19,911 - $200,859	19,332 New	19,332 $190,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.